Amphastar Pharmaceuticals Files 8-K on Corporate Matters
Ticker: AMPH · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1297184
| Field | Detail |
|---|---|
| Company | Amphastar Pharmaceuticals, Inc. (AMPH) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
Related Tickers: AMPH
TL;DR
AMPH filed an 8-K covering corporate changes and shareholder votes.
AI Summary
On June 2, 2025, Amphastar Pharmaceuticals, Inc. filed an 8-K report detailing amendments to its Articles of Incorporation or Bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company, incorporated in Delaware with its principal executive offices in Rancho Cucamonga, CA, operates in the pharmaceutical preparations industry.
Why It Matters
This filing indicates potential changes in Amphastar's corporate structure or governance, which could impact its operational direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is procedural and relates to corporate governance rather than immediate financial performance or significant operational shifts.
Key Players & Entities
- Amphastar Pharmaceuticals, Inc. (company) — Registrant
- June 2, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Rancho Cucamonga, CA (location) — Address of principal executive offices
- 909-980-9484 (phone_number) — Registrant's telephone number
FAQ
What specific amendments were made to Amphastar Pharmaceuticals' Articles of Incorporation or Bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What matters were submitted to a vote of Amphastar Pharmaceuticals' security holders?
The filing states that matters were submitted to a vote, but the nature of these matters is not specified in the provided text.
What financial statements and exhibits are included in this 8-K filing?
The filing mentions the inclusion of financial statements and exhibits, but their specific content is not detailed in the summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 2, 2025.
Where are Amphastar Pharmaceuticals, Inc.'s principal executive offices located?
Amphastar Pharmaceuticals, Inc.'s principal executive offices are located at 11570 Sixth Street, Rancho Cucamonga, CA 91730.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Amphastar Pharmaceuticals, Inc. (AMPH).